Free Trial
NASDAQ:TRIB

Trinity Biotech (TRIB) Stock Price, News & Analysis

Trinity Biotech logo
$0.70 +0.05 (+7.42%)
Closing price 03:59 PM Eastern
Extended Trading
$0.70 0.00 (-0.03%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Trinity Biotech Stock (NASDAQ:TRIB)

Key Stats

Today's Range
$0.65
$0.70
50-Day Range
$0.55
$0.85
52-Week Range
$0.48
$3.44
Volume
231,016 shs
Average Volume
1.11 million shs
Market Capitalization
$12.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Trinity Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

TRIB MarketRank™: 

Trinity Biotech scored higher than 15% of companies evaluated by MarketBeat, and ranked 881st out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Trinity Biotech.

  • Earnings Growth

    Earnings for Trinity Biotech are expected to grow in the coming year, from ($1.51) to ($0.90) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Trinity Biotech is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Trinity Biotech is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Trinity Biotech's valuation and earnings.
  • Percentage of Shares Shorted

    0.25% of the float of Trinity Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Trinity Biotech has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Trinity Biotech has recently increased by 20.69%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Trinity Biotech does not currently pay a dividend.

  • Dividend Growth

    Trinity Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.25% of the float of Trinity Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Trinity Biotech has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Trinity Biotech has recently increased by 20.69%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Trinity Biotech has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Trinity Biotech this week, compared to 1 article on an average week.
  • MarketBeat Follows

    Only 1 people have added Trinity Biotech to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Trinity Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.20% of the stock of Trinity Biotech is held by insiders.

  • Percentage Held by Institutions

    78.97% of the stock of Trinity Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Trinity Biotech's insider trading history.
Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

TRIB Stock News Headlines

3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
See More Headlines

TRIB Stock Analysis - Frequently Asked Questions

Trinity Biotech's stock was trading at $0.8802 at the beginning of the year. Since then, TRIB shares have decreased by 20.7% and is now trading at $0.6982.
View the best growth stocks for 2025 here
.

Trinity Biotech PLC (NASDAQ:TRIB) released its earnings results on Monday, May, 24th. The company reported $0.50 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.15. The business earned $25.59 million during the quarter.
Read the conference call transcript
.

Shares of Trinity Biotech reverse split on the morning of Wednesday, February 21st 2024.The 1-5 reverse split was announced on Wednesday, February 21st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 21st 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trinity Biotech investors own include Bristol Myers Squibb (BMY), Micron Technology (MU), OPKO Health (OPK), Novavax (NVAX), Corbus Pharmaceuticals (CRBP), Gilead Sciences (GILD) and Pfizer (PFE).

Company Calendar

Last Earnings
5/24/2021
Today
7/01/2025
Next Earnings (Estimated)
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TRIB
Employees
480
Year Founded
1992

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.79 million
Pretax Margin
-49.92%

Debt

Sales & Book Value

Annual Sales
$61.56 million
Price / Cash Flow
N/A
Book Value
($1.95) per share
Price / Book
-0.36

Miscellaneous

Free Float
16,574,000
Market Cap
$12.60 million
Optionable
Optionable
Beta
0.84

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:TRIB) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners